Navigation Links
Horizon Therapeutics Announces Senior Management Appointments
Date:1/6/2009

SKOKIE, Ill., Jan. 6 /PRNewswire/ -- Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced the appointment of Amy Grahn to vice president, clinical operations and Iain Duncan to senior vice president of operations.

"Amy and Iain bring valuable operations experience that is vital as we prepare regulatory filings in the U.S. and Europe and move forward with the anticipated commercialization of our lead product candidate, HZT-501," said Timothy P. Walbert, president and chief executive officer. "During their respective careers, Amy and Iain have been instrumental in the growth of start-up as well as established biotech and pharmaceutical companies and their leadership will be an important part of Horizon's future growth."

Ms. Grahn has more than 20 years pharmaceutical industry experience spanning pre-clinical research to sales, with a primary focus on clinical operations. Ms. Grahn was most recently vice president of clinical operations at MedGenesis Therapeutix Inc. in British Columbia, Canada where she was responsible for strategic planning, development and implementation of clinical and pre-clinical development plans for therapeutic agents delivered via the MedGenesis convection-enhanced delivery (CED) platform.

During her career, Ms. Grahn has held various senior level positions at Neopharm, Inc., Takeda Pharmaceuticals North America, Inc., G.D. Searle & Company and Abbott Laboratories.

At Horizon, Ms. Grahn will lead all clinical operations activities. Ms. Grahn has a master's degree in biochemistry from Illinois Institute of Technology in Chicago and a bachelor's degree in chemistry and biology from Knox College in Galesburg, Ill.

Mr. Duncan has more than 20 years executive-level management experience in international, general and operations management. Mr. Duncan was a co-founder of Corus Pharma, I
'/>"/>

SOURCE Horizon Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer
2. Horizon Therapeutics to Present at JMP Securities Healthcare Focus Conference
3. Horizon Therapeutics to Present at UBS Global Life Sciences Conference
4. Horizon Therapeutics Announces Corporate Relocation to the Chicago Area
5. BioHorizons Global Symposium 2008 Combines Record Attendance with Groundbreaking Technology
6. BioHorizons Announces the Purchase of Implant Logic Systems
7. Caliper Life Sciences Forms Alliance With Horizon Discovery to Provide Enhanced Solutions for Cancer Research Based on Isogenic Cell Lines
8. Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
9. BioHorizons Announces Agreement to Purchase Implant Logic Systems
10. Out beyond the horizon
11. Out beyond the horizon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... October 18, 2014 The Asia-Pacific Liquid ... segments the concerned market in Asia-Pacific with analysis and ... million in 2013, and is expected to reach $380.0 ... 2013 to 2018. , Browse through the TOC of ... idea of the in-depth analysis provided. This also provides ...
(Date:10/18/2014)... October 18, 2014 According to a ... & Well Type - Global Trends & Forecasts up ... $31 billion in 2011. This value is expected to ... by 2017, with 10% CAGR during the same period. ... fracturing production market in terms of hydraulic horse power ...
(Date:10/17/2014)... have received a $451,781 Air Force Office of Scientific ... micro- and nano-scale level that will provide clues for ... Mechanical and Aerospace Engineering, said the new technology and ... X-rays of an aircraft,s wing., "We,ll be able to ... look at it on this scale," Huang said. "Certain ...
(Date:10/17/2014)... DE (PRWEB) October 17, 2014 ... among top employers, as published in today’s print ... Science Careers’ annual Top Employers Survey polled employees ... determine the 20 best employers. Rankings were ... were asked to rate their companies on 23 ...
Breaking Biology Technology:The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Liquid Crystal on Silicon (LCoS) display market is expected to reach $380.0 million by 2018 - New Report by MicroMarket Monitor 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 2Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 4UT Arlington project to detect possible damages in aircraft parts early in process 2DuPont Named Top Employer by Science Magazine 2DuPont Named Top Employer by Science Magazine 3
... - Prevenar Vaccine to Help Protect ... in Young Children Worldwide, Wyeth today ... Ireland have,initiated national immunisation programmes (NIPs) for ... adding Prevenar(TM) (Pneumococcal,Saccharide Conjugated Vaccine, Adsorbed), also ...
... has partnered,with ResMed, a leading manufacturer of medical ... a new wireless,technology used to monitor patients with ... technology is intended to more easily,provide data that ... care for those,requiring PAP treatment., "We take ...
... -- China Bio Energy,Holdings (OTC Bulletin Board: ... in the Susquehanna Second Annual Beijing Management ... Management,s participation will consist,of a presentation scheduled ... a.m.,local time as well one-on-one meetings with ...
Cached Biology Technology:Cyprus and Ireland Add Wyeth's 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules 2Cyprus and Ireland Add Wyeth's 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to Their National Immunisation Schedules 3Latest Sleep Disorder Technology Tested With SleepQuest 2China Bio Energy Holdings Group Announces Participation in the Susquehanna Second Annual Beijing Management Summit 2
(Date:10/15/2014)... awarded the 44th Rosenstiel Award for Distinguished Work in ... exploring the mechanisms of genomic instability and its implications ... the second alumnus to win the Rosenstiel Award; the ... , Alt is the Charles A. Janeway Professor of ... and an investigator at the Howard Hughes Medical Institute ...
(Date:10/14/2014)... Like discriminating thieves, prostate cancer tumors scavenge and hoard ... But such avarice may be a fatal weakness. ... to kill prostate cancer cells by delivering a trove ... the diseased cells brimming with the mineral, leaving non-cancer ... drugs already commercially available for other uses, could soon ...
(Date:10/14/2014)... Ohio (Oct. 14, 2014)—It,s been millions of years since ... a team led by Ohio University scientists is breathing ... model airflow through dinosaur snouts. The research has important ... only breathe but to enhance the sense of smell ... ,nosy, animals," said Ohio University doctoral student Jason Bourke, ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Prostate cancer's penchant for copper may be a fatal flaw 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3
... today announced that two Fred Hutchinson Cancer Research ... honor for scientists at the beginning of their ... Ph.D., and cancer-prevention researcher Ulrike "Riki" Peters, Ph.D., ... 2008 Presidential Early Career Award for Scientists and ...
... Springer will publish The HUGO Journal in cooperation ... Springer as Genomic Medicine, The HUGO Journal has ... Members of HUGO will receive free access to the ... discounted rates. The HUGO Journal will focus ...
... 40 member organizations of the International Tiger Coalition (ITC) applaud ... farming is too great a gamble for the world to ... wild. "Having carefully weighed the economics argument, we ... tiger products and for all countries to continue to ban ...
Cached Biology News:2 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 22 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 32 Fred Hutchinson Cancer Research Center scientists receive Presidential Early Career Award 4